An interventional study of GMT in Schizophrenia and Neurocognitive Disorders, sponsored by Sykehuset Innlandet HF. Completed at 1 site in Norway. Open to participants aged 16 Years to 67 Years. Per ClinicalTrials.gov, last updated 2021-02-10.
Sponsored by Sykehuset Innlandet HF · Not applicable, Interventional, and Treatment
About 85% of patients with schizophrenia have cognitive impairments, executive functions being particularly affected. Executive dysfunction, and cognitive deficits in general, are important predictors of functional outcomes, including social problem solving, activities of daily living, life satisfaction, and the ability to return to work or school.The main objective of the current study is to examine the efficacy of group-based Goal Management Training (GMT) for patients with broad schizophrenia spectrum disorders or high risk individuals with executive deficits. The short term goals are to investigate whether GMT can improve participants' ability to organize and achieve goals in everyday life in addition to improving aspects of emotional health. A long-term goal would be to establish an evidence base for nonpharmacological interventions for patients with broad schizophrenia spectrum disorders or high risk for schizophrenia. Main research questions: (1) Does a RCT with GMT delivered to patients with broad schizophrenia spectrum disorders or high risk for schizophrenia result in improved executive functioning, measured by self-reported and/or objective measures of executive functions? (2) Does GMT result in improved goal attainment in everyday life, social- and real world functioning? (3) Does GMT have a positive impact on the patients' emotional health? (4) Are there specific characteristics in patients with broad schizophrenia spectrum disorders or high risk for schizophrenia that are associated with better treatment benefit from GMT?
3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.
This study's enrollment of 83 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →Sykehuset Innlandet HF is the lead sponsor of 50 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Cognitive rehabilitation
Behavioral: GMT
Metacognitive strategy training where the primary objective is to stop ongoing behavior to define goal hierarchies and monitor performance
Behavior Rating Inventory for Executive Functions
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Conners Continuous Performance Test III
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Positive and Negative Syndrome Scale
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Global Assessment of Functioning-Split Version
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
The Hotel Task
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Delis Kaplan Executive Function System (D-KEFS) subtests
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Digit span and Letter-number sequencing
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Iowa Gambling Task
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Dysexecutive Questionnaire (self-and informant)
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Cognitive Failures Questionnaire
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Goal Attainment Scaling
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Everyday Functioning from NORMENT Long time follow up questionnaires
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
General Perceived Self-Efficacy Scale
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Social Functioning Scale
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
The Perceived Quality of Life Scale
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Rosenberg self-esteem scale
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
Hopkins Symptom Checklist 10
Assessing change
Time frame: Baseline, immediately post-intervention and 6 months follow-up
This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sykehuset Innlandet HF